1. Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
- Author
-
Grasso, Catherine S., primary, Tsoi, Jennifer, additional, Onyshchenko, Mykola, additional, Abril-Rodriguez, Gabriel, additional, Ross-Macdonald, Petra, additional, Wind-Rotolo, Megan, additional, Champhekar, Ameya, additional, Medina, Egmidio, additional, Torrejon, Davis Y., additional, Shin, Daniel Sanghoon, additional, Tran, Phuong, additional, Kim, Yeon Joo, additional, Puig-Saus, Cristina, additional, Campbell, Katie, additional, Vega-Crespo, Agustin, additional, Quist, Michael, additional, Martignier, Christophe, additional, Luke, Jason J., additional, Wolchok, Jedd D., additional, Johnson, Douglas B., additional, Chmielowski, Bartosz, additional, Hodi, F. Stephen, additional, Bhatia, Shailender, additional, Sharfman, William, additional, Urba, Walter J., additional, Slingluff, Craig L., additional, Diab, Adi, additional, Haanen, John B.A.G., additional, Algarra, Salvador Martin, additional, Pardoll, Drew M., additional, Anagnostou, Valsamo, additional, Topalian, Suzanne L., additional, Velculescu, Victor E., additional, Speiser, Daniel E., additional, Kalbasi, Anusha, additional, and Ribas, Antoni, additional
- Published
- 2021
- Full Text
- View/download PDF